AtriCure Income from Continuous Operations 2010-2025 | ATRC
AtriCure income from continuous operations from 2010 to 2025. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
| AtriCure Annual Income from Continuous Operations (Millions of US $) |
|
|---|---|
| 2024 | $-45 |
| 2023 | $-30 |
| 2022 | $-46 |
| 2021 | $50 |
| 2020 | $-48 |
| 2019 | $-35 |
| 2018 | $-21 |
| 2017 | $-27 |
| 2016 | $-33 |
| 2015 | $-27 |
| 2014 | $-16 |
| 2013 | $-11 |
| 2012 | $-8 |
| 2011 | $-5 |
| 2010 | $-4 |
| 2009 | $-16 |
| AtriCure Quarterly Income from Continuous Operations (Millions of US $) |
|
|---|---|
| 2025-06-30 | $-6 |
| 2025-03-31 | $-7 |
| 2024-12-31 | $-16 |
| 2024-09-30 | $-8 |
| 2024-06-30 | $-8 |
| 2024-03-31 | $-13 |
| 2023-12-31 | $-10 |
| 2023-09-30 | $-9 |
| 2023-06-30 | $-5 |
| 2023-03-31 | $-6 |
| 2022-12-31 | $-4 |
| 2022-09-30 | $-12 |
| 2022-06-30 | $-15 |
| 2022-03-31 | $-15 |
| 2021-12-31 | $-14 |
| 2021-09-30 | $97 |
| 2021-06-30 | $-16 |
| 2021-03-31 | $-17 |
| 2020-12-31 | $-19 |
| 2020-09-30 | $-5 |
| 2020-06-30 | $-8 |
| 2020-03-31 | $-16 |
| 2019-12-31 | $-16 |
| 2019-09-30 | $-9 |
| 2019-06-30 | $-4 |
| 2019-03-31 | $-6 |
| 2018-12-31 | $-3 |
| 2018-09-30 | $-7 |
| 2018-06-30 | $0 |
| 2018-03-31 | $-10 |
| 2017-12-31 | $-3 |
| 2017-09-30 | $-7 |
| 2017-06-30 | $-7 |
| 2017-03-31 | $-10 |
| 2016-12-31 | $-9 |
| 2016-09-30 | $-7 |
| 2016-06-30 | $-8 |
| 2016-03-31 | $-10 |
| 2015-12-31 | $-11 |
| 2015-09-30 | $-6 |
| 2015-06-30 | $-5 |
| 2015-03-31 | $-5 |
| 2014-12-31 | $-5 |
| 2014-09-30 | $0 |
| 2014-06-30 | $-3 |
| 2014-03-31 | $-8 |
| 2013-12-31 | $-5 |
| 2013-09-30 | $-3 |
| 2013-06-30 | $-2 |
| 2013-03-31 | $-2 |
| 2012-12-31 | $-2 |
| 2012-09-30 | $-3 |
| 2012-06-30 | $-1 |
| 2012-03-31 | $-2 |
| 2011-12-31 | $-2 |
| 2011-09-30 | $-1 |
| 2011-06-30 | $-1 |
| 2011-03-31 | $-1 |
| 2010-12-31 | $0 |
| 2010-09-30 | $-1 |
| 2010-06-30 | $-1 |
| 2010-03-31 | $-2 |
| 2009-12-31 | $-2 |
| 2009-09-30 | $-5 |
| 2009-06-30 | $-1 |
| 2009-03-31 | $-8 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.762B | $0.465B |
| AtriCure, Inc. is a medical device company focused on developing, manufacturing and selling innovative surgical devices to create precise lesions, or scars, in soft tissues. Medical journals have described the adoption by leading cardiothoracic surgeons of the AtriCure, Inc. bipolar ablation system as a standard treatment alternative during open-heart surgical procedures to safely, rapidly and reliably create lesions in cardiac, or heart, tissue to block the abnormal electrical impulses that cause atrial fibrillation, a quivering of the upper chambers of the heart. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $229.305B | 26.89 |
| Boston Scientific (BSX) | United States | $152.872B | 36.46 |
| Stryker (SYK) | United States | $146.007B | 29.72 |
| EssilorLuxottica (ESLOY) | France | $145.127B | 0.00 |
| Medtronic (MDT) | Ireland | $119.234B | 16.91 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.282B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.347B | 24.74 |
| ResMed (RMD) | United States | $41.712B | 29.83 |
| Agilent Technologies (A) | United States | $33.861B | 22.07 |
| GE HealthCare Technologies (GEHC) | United States | $33.512B | 15.75 |
| Terumo (TRUMY) | Japan | $27.642B | 32.75 |
| Koninklijke Philips (PHG) | Netherlands | $26.451B | 17.50 |
| Insulet (PODD) | United States | $22.615B | 75.77 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.354B | 12.96 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $15.855B | 0.00 |
| Baxter (BAX) | United States | $12.419B | 9.60 |
| Sunny Optical Technology (SNPTF) | China | $10.800B | 0.00 |
| Demant (WILYY) | Denmark | $8.121B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.731B | 28.40 |
| Lantheus Holdings (LNTH) | United States | $3.684B | 9.96 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.430B | 24.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.198B | 14.19 |
| Perrigo (PRGO) | Ireland | $3.123B | 7.80 |
| ICU Medical (ICUI) | United States | $2.986B | 20.33 |
| Haemonetics (HAE) | United States | $2.589B | 11.56 |
| LeMaitre Vascular (LMAT) | United States | $2.171B | 46.56 |
| Curaleaf Holdings (CURLF) | Canada | $1.782B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.761B | 11.08 |
| Green Thumb Industries (GTBIF) | United States | $1.601B | 68.73 |
| AdaptHealth (AHCO) | United States | $1.283B | 18.24 |
| Phibro Animal Health (PAHC) | United States | $1.243B | 15.89 |
| Acuren (TIC) | United States | $1.190B | 0.00 |
| Neogen (NEOG) | United States | $1.179B | 18.72 |
| BioLife Solutions (BLFS) | United States | $1.166B | 2434.00 |
| Tilray Brands (TLRY) | Canada | $1.134B | 0.00 |
| Valneva SE (VALN) | France | $0.981B | 0.00 |
| InMode (INMD) | Israel | $0.907B | 8.39 |
| Kestra Medical Technologies (KMTS) | United States | $0.824B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.665B | 0.00 |
| Surmodics (SRDX) | United States | $0.536B | 0.00 |
| ZimVie (ZIMV) | United States | $0.532B | 20.49 |
| SNDL (SNDL) | Canada | $0.531B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.482B | 0.00 |
| CeriBell (CBLL) | United States | $0.451B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.451B | 15.53 |
| Owens & Minor (OMI) | United States | $0.439B | 3.89 |
| Verano Holdings (VRNOF) | United States | $0.438B | 0.00 |
| Evolus (EOLS) | United States | $0.435B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.364B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.331B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.330B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.312B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.287B | 0.00 |
| Omeros (OMER) | United States | $0.272B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.267B | 20.26 |
| Sanara MedTech (SMTI) | United States | $0.264B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.254B | 0.00 |
| Brainsway (BWAY) | Israel | $0.245B | 49.92 |
| Cerus (CERS) | United States | $0.238B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.234B | 0.00 |
| High Tide (HITI) | Canada | $0.216B | 0.00 |
| Quanterix (QTRX) | United States | $0.212B | 0.00 |
| Exagen (XGN) | United States | $0.209B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.202B | 0.00 |
| Organigram Global (OGI) | Canada | $0.192B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.178B | 14.83 |
| TriSalus Life Sciences (TLSI) | United States | $0.172B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.156B | 19.20 |
| Biote (BTMD) | United States | $0.144B | 4.79 |
| Jushi Holdings (JUSHF) | United States | $0.116B | 0.00 |
| MacroGenics (MGNX) | United States | $0.100B | 0.00 |
| Jin Medical (ZJYL) | China | $0.096B | 0.00 |
| Fonar (FONR) | United States | $0.094B | 12.08 |
| Quipt Home Medical (QIPT) | United States | $0.089B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.085B | 0.00 |
| Apyx Medical (APYX) | United States | $0.082B | 0.00 |
| Safety Shot (SHOT) | United States | $0.078B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.073B | 0.00 |
| Agape ATP (ATPC) | $0.063B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.055B | 32.12 |
| Veru (VERU) | United States | $0.053B | 0.00 |
| Zynex (ZYXI) | United States | $0.046B | 0.00 |
| Nephros (NEPH) | United States | $0.045B | 35.42 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.036B | 14.05 |
| Rockwell Medical (RMTI) | United States | $0.035B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.029B | 0.00 |
| Senestech (SNES) | United States | $0.024B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.008B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |